Back to Assenagon Asset Management S.A. Assenagon Asset Management S.A.

DCPHDCPH
13 quarters

Position history for Assenagon Asset Management S.A.Assenagon Asset Management S.A.'s holdings in DECIPHERA PHARMACEUTICALS IN

As of its Q1 2024 13F, Assenagon Asset Management held 809,923 shares of DCPH (Deciphera Pharmaceuticals in), worth $12.7M. Assenagon Asset Management's 13F filings listed DCPH from Q2 2021 to Q1 2024, 12 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$951,000

Total Shares Change

-25,974

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Unchanged
809,923
0.0%
$12.7M0.0%—
0
2023-Q4
Unchanged
809,923
0.0%
$13.1M0.0%—
0
2023-Q3
Decreased
809,923
-4.6%
$10.3M0.0%—
0
2023-Q2
Unchanged
848,632
0.0%
$11.9M0.0%—
0
2023-Q1
Decreased
848,632
-16.5%
$13.1M0.0%—
0
2022-Q4
Decreased
1M
-27.6%
$16.7M0.1%—
0
2022-Q3
Increased
1.4M
+99.2%
$26M0.1%—
46
2022-Q2
Decreased
704,750
-17.6%
$9.3M0.0%—
0
2022-Q1
Increased
855,699
+250.2%
$7.9M0.0%—
44
2021-Q4
Increased
244,365
+897.8%
$2.4M0.0%—
42
2021-Q3
Decreased
24,491
-5.7%
$832,0000.0%—
0
2021-Q2
New
25,974
-
$951,0000.0%—
35

Other major holders of DCPH: FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used